Ownership Summary
Recent 13F filings as of December 2025 show that 5 institutional investors hold a position in PureTech Health plc (NASDAQ:PRTC).
- These investors collectively held 0.3% of the company's total shares outstanding in December 2025, down from 47.7% in September 2025.
- On a quarter-over-quarter basis, institutional holdings shifted by -7.08%, with a year-over-year a decrease of 16.67% in the count of filers.
- During the quarter, 2 institutions bought more PureTech Health shares, 2 sold shares, and 1 of the 5 total investors held their position steady.
- The aggregate institutional position in PureTech Health now stands at 94.66K shares as of December 2025, after investors decreased their holdings (down by 7.21K shares quarter on quarter which is down 278.72K shares year over year).
- Pentwater Capital Management LP continues to be the largest institutional holder of PureTech Health as of December 31, 2025, with a position of 70.00K shares, representing 0.23% of the company's outstanding stock.
- Among the most significant buyers of PureTech Health during December 2025 were DIADEMA PARTNERS LP (118), Persistent Asset Partners Ltd (74).
- Leading sellers of PureTech Health stock in December 2025 included Pentwater Capital Management LP (5.00K), MILLENNIUM MANAGEMENT LLC (2.41K).
- The top 5 institutional holders of PureTech Health for the quarter ending December 2025 included Pentwater Capital Management LP (70.00K), MILLENNIUM MANAGEMENT LLC (15.44K), DIADEMA PARTNERS LP (7.44K), Persistent Asset Partners Ltd (1.76K), UBS Group AG (20).